The present invention relates to a pharmaceutical composition for the treatment of skin wounds containing CTRP3 (C1q / TNF-related protein-3) as an active ingredient. The composition can promptly remove damaged skin and, as a result, So that it can be usefully used for skin wound treatment or wound regeneration.
展开▼
